Clinical trial
Insulin Balanced Infusion System Control of Glucose
NCT01291719 is registered in ClinicalTrials.gov with Admetsys Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Insulin Balanced Infusion System Control of Glucose
- Lead sponsor
- Admetsys Corporation
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- November 30, 2008
- Completion date
- November 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, hyperglycemia